Rigel Pharmaceuticals RIGL Single reportable segment — Commercial related expenses

Similar metrics at other companies

RYTMSingle reportable segment — Commercial & medical affairs

$20.26M+52.9%

CRNXReportable Segment — Commercial Selling, General And Administrative Personnel Expenses

$20.04M+65.7%

MIRMReportable Segment — Commercialization and Medical Affairs expenses (excluding stock-based compensation)

$44.22M+23.6%

AQSTReportable Segment — Total Selling expenses

$1.92M-35.0%

ARDXReportable Segment — Selling

$67.4M+18.7%

INCYReportable Segment — Sales and marketing

$259.56M+0.7%

Other financials

Income statement

See full

Revenue$58.8M+10.3%

Gross profit$54.2M+10.8%

Operating income$11.9M-7.0%

Net income$8.7M-24.4%

EPS (diluted)$0.44-30.2%

Balance sheet

See full

Cash & equivalents$24.5M-46.6%

Total debt$68.4M+5,079%

Total equity$399.9M+2,054%

Total assets$504.6M+187%

Cash flow

See full

Operating cash flow$2.7M+405%

CapEx$73.0K—

Free cash flow-$22.0M—

Valuation

See full

Market cap$684.39M+102%

Enterprise value$728.29M+148%

P/E1.9×-7.2×

P/S2.3×+0.6×

Profitability

See full

Gross margin93.4%+3.7pp

Operating margin41.6%+19.9pp

Net margin121.5%+103pp

FCF margin-61.7%—

Returns & leverage

See full

Return on equity174.1%—

Debt / equity0.2×+0.1×

Current ratio2.6×+0.4×

Where this comes from

Reported directly by Rigel Pharmaceuticals in its filing.

Tagged under the XBRL concept rigl:CommercialRelatedExpenses.

The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rigel Pharmaceuticals's single reportable segment — commercial related expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rigel Pharmaceuticals's single reportable segment — commercial related expenses?: Rigel Pharmaceuticals (RIGL) reported single reportable segment — commercial related expenses of $7.04M in Q1 2026.
What does single reportable segment — commercial related expenses mean?: Captures the costs incurred for marketing, sales force support, and commercialization activities for the company's pharmaceutical products. This metric indicates the level of investment required to drive market adoption and product awareness.